Hamulyak K - Search Results

1

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.

Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MM, van Pampus EC, Prins MH, Büller HR, van der Meer J. Libourel EJ, et al. Among authors: hamulyak k. Haematologica. 2002 Oct;87(10):1068-73. Haematologica. 2002. PMID: 12368162

2

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: hamulyak k. Br J Haematol. 2002 Mar;116(3):625-31. doi: 10.1046/j.0007-1048.2001.03303.x. Br J Haematol. 2002. PMID: 11849222 Free article.

3

High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study.

Libourel EJ, Baljé-Volkers Degrees CP, Hamulyàk K, Prins MH, Middeldorp S, Büller HR, van der Meer J. Libourel EJ, et al. Among authors: hamulyak k. Haematologica. 2004 Jan;89(1):118-20. Haematologica. 2004. PMID: 14754621 No abstract available.

4

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Bank I, et al. Among authors: hamulyak k. Arch Intern Med. 2004 Sep 27;164(17):1932-7. doi: 10.1001/archinte.164.17.1932. Arch Intern Med. 2004. PMID: 15451770

5

Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.

Libourel EJ, Bank I, Veeger NJ, Hamulyàk K, Middeldorp S, Prins MH, Büller HR, van der Meer J. Libourel EJ, et al. Among authors: hamulyak k. Blood Coagul Fibrinolysis. 2005 Mar;16(2):135-40. doi: 10.1097/01.mbc.0000161567.59140.47. Blood Coagul Fibrinolysis. 2005. PMID: 15741801

6

The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.

Lijfering WM, Coppens M, van de Poel MH, Middeldorp S, Hamulyák K, Bank I, Veeger NJ, Prins MH, Büller HR, van der Meer J. Lijfering WM, et al. Among authors: hamulyak k. Thromb Haemost. 2007 Aug;98(2):457-63. Thromb Haemost. 2007. PMID: 17721631

7

Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.

Lijfering WM, Coppens M, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Lijfering WM, et al. Among authors: hamulyak k. Thromb Res. 2008;123(2):244-50. doi: 10.1016/j.thromres.2007.12.010. Epub 2008 Feb 14. Thromb Res. 2008. PMID: 18279917 No abstract available.

8

Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.

Folkeringa N, Korteweg FJ, Veeger NJ, Middeldorp S, Hamulyak K, Prins MH, Erwich JJ, Büller HR, van der Meer J. Folkeringa N, et al. Among authors: hamulyak k. Thromb Res. 2009;123(3):511-4. doi: 10.1016/j.thromres.2008.02.014. Epub 2008 May 2. Thromb Res. 2009. PMID: 18455758 No abstract available.

9

Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.

Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J. Folkeringa N, et al. Among authors: hamulyak k. Thromb Haemost. 2008 Jul;100(1):38-44. doi: 10.1160/TH07-11-0659. Thromb Haemost. 2008. PMID: 18612536

10

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Lijfering WM, et al. Among authors: hamulyak k. Blood. 2009 May 21;113(21):5314-22. doi: 10.1182/blood-2008-10-184879. Epub 2009 Jan 12. Blood. 2009. PMID: 19139080 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters